PL2957280T3 - Stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania - Google Patents

Stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania

Info

Publication number
PL2957280T3
PL2957280T3 PL15001790T PL15001790T PL2957280T3 PL 2957280 T3 PL2957280 T3 PL 2957280T3 PL 15001790 T PL15001790 T PL 15001790T PL 15001790 T PL15001790 T PL 15001790T PL 2957280 T3 PL2957280 T3 PL 2957280T3
Authority
PL
Poland
Prior art keywords
cytisine
preparation
pharmaceutical composition
solid pharmaceutical
solid
Prior art date
Application number
PL15001790T
Other languages
English (en)
Inventor
Katarzyna Berdzińska
Hanna Kierońska
Marek Milewski
Małgorzata Nawrocka
Marta Klepczyńska
Original Assignee
Bonteque Consulting Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54011933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2957280(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bonteque Consulting Ltd filed Critical Bonteque Consulting Ltd
Publication of PL2957280T3 publication Critical patent/PL2957280T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL15001790T 2014-06-18 2015-06-17 Stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania PL2957280T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL408608A PL408608A1 (pl) 2014-06-18 2014-06-18 Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
EP15001790.3A EP2957280B1 (en) 2014-06-18 2015-06-17 Solid pharmaceutical composition of cytisine and process for preparation thereof

Publications (1)

Publication Number Publication Date
PL2957280T3 true PL2957280T3 (pl) 2019-09-30

Family

ID=54011933

Family Applications (2)

Application Number Title Priority Date Filing Date
PL408608A PL408608A1 (pl) 2014-06-18 2014-06-18 Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
PL15001790T PL2957280T3 (pl) 2014-06-18 2015-06-17 Stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL408608A PL408608A1 (pl) 2014-06-18 2014-06-18 Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania

Country Status (12)

Country Link
EP (1) EP2957280B1 (pl)
CY (1) CY1121986T1 (pl)
DK (1) DK2957280T3 (pl)
ES (1) ES2732711T3 (pl)
HR (1) HRP20191217T1 (pl)
HU (1) HUE044804T2 (pl)
LT (1) LT2957280T (pl)
PL (2) PL408608A1 (pl)
PT (1) PT2957280T (pl)
RS (1) RS58983B1 (pl)
SI (1) SI2957280T1 (pl)
TR (1) TR201909836T4 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201602145D0 (en) * 2016-02-05 2016-03-23 Achieve Pharma Uk Ltd Salt
EP3598968A1 (en) 2018-07-23 2020-01-29 Adamed Pharma S.A. Solid pharmaceutical cytisine composition
BG67408B1 (bg) * 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости
CN115487158A (zh) * 2021-06-18 2022-12-20 北京万全德众医药生物技术有限公司 一种金雀花碱片剂及其制备方法
US20250186417A1 (en) * 2023-12-12 2025-06-12 Achieve Life Sciences, Inc. Cytisine formulations
WO2025128716A1 (en) * 2023-12-12 2025-06-19 Achieve Life Sciences, Inc. Smoking cessation compounds having reduced nitrosamines and associated methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983002892A1 (fr) 1982-02-22 1983-09-01 Talapin, Vitaly, Ivanovich Preparation medicinale possedant un effet antinicotine et son procede d'obtention
UA59365C2 (uk) 1996-05-20 2003-09-15 Андрєй Зіновьєвіч Вітік Похідні цитизину, що містять фосфор
BG65536B1 (bg) 2004-04-16 2008-11-28 "Софарма" Ад Лекарствена форма, съдържаща цитизин
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
PL220354B1 (pl) 2012-11-19 2015-10-30 Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania

Also Published As

Publication number Publication date
RS58983B1 (sr) 2019-08-30
TR201909836T4 (tr) 2019-07-22
ES2732711T3 (es) 2019-11-25
HUE044804T2 (hu) 2019-11-28
EP2957280A1 (en) 2015-12-23
EP2957280B1 (en) 2019-04-17
PL408608A1 (pl) 2015-12-21
LT2957280T (lt) 2019-07-25
HRP20191217T1 (hr) 2019-10-18
DK2957280T3 (da) 2019-07-22
PT2957280T (pt) 2019-07-23
CY1121986T1 (el) 2020-10-14
SI2957280T1 (sl) 2019-08-30

Similar Documents

Publication Publication Date Title
IL250744A0 (en) A method for preparing flavociclib and its pharmaceutical preparations
GB201817116D0 (en) Pharmaceutical preparation of palbociclic and preparation method thereof
GB201409471D0 (en) Pharmaceutical composition
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
GB201409488D0 (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
ZA201601656B (en) Inhalable pharmaceutical composition
ZA201703398B (en) Pharmaceutical composition and methods
PT2957280T (pt) Composição farmacêutica sólida de citisina e processo para a sua preparação
PL3391893T3 (pl) Kompozycja farmaceutyczna do leczenia białaczki i sposób jej przygotowania
ZA201700843B (en) Oral pharmaceutical composition of isotretinoin
ZA201508726B (en) Pharmaceutical composition
ZA201502073B (en) Pharmaceutical composition
GB201406172D0 (en) Therapy and pharmaceutical composition
PT3503885T (pt) Composição farmacêutica e métodos de utilização
IL251559A0 (en) Pharmaceutical preparations of the history of aminodihydrothiazines from Amano
GB201718475D0 (en) Pharmaceutical composition for treatment of depression and preparation method thereof
PL3250188T3 (pl) Kompozycja farmaceutyczna zawierająca Aprepitant oraz sposób jej wytwarzania
SMT202000391T1 (it) Composizione farmaceutica
HUP1400543A2 (hu) Eljárás és köztitermék apixaban elõállítására
GB201718483D0 (en) Pharmaceutical composition for treatment of meopausal syndrome and preparation method thereof
HUP1500647A2 (en) Intermediate of baricitinib and process for its preparation
SG11201608250YA (en) Polymer powder composition and its method of preparation
SG10201504332VA (en) Pharmaceutical Composition
IL266938A (en) Pharmaceutical preparation and method for its production